Latest Federal Register Notices

Pediatric Oncology Meeting Planned for 6/21-22
Federal Register notice: FDA announces a 6/21-22 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee meeting.
06/8/2017

FDA Vaccines Panel Meeting to Review Hep B Vaccine
Federal Register notice: FDA announces a 7/28 Vaccines and Related Biological Products Advisory Committee meeting that will vote on a Hepatitis B Vaccine manufactured by Dynavax.
06/8/2017

Comments on Criteria for OTC Drugs Seen as GRASE
Federal Register notice: FDA seeks comments on an information collection revision to “Additional Criteria and Procedures for Classifying Over- the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded.”
06/7/2017

Comments Sought on eSubmitted Allegations to CDRH
Federal Register notice: FDA seeks comments on an information collection extension for “Electronic Submission Process for Voluntary Allegations to the Center for Devices and Radiological Health.”
06/7/2017